SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-01-524320
Filing Date
2001-07-18
Accepted
2001-07-18 00:00:00
Documents
7
Group Members
CLAL BIOTECHNOLOGY INDUSTRIES LTD.CLAL INDUSTRIES AND INVESTMENTS LTD.ELAINE RECANATIIDB DEVELOPMENT CORPORATION LTD.IDB HOLDING CORP LTDJUDITH YOVEL RECANATILEON RECANATIOUDI RECANATI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A a2054480zsc13da.txt SC 13D/A 37166
2 EXHIBIT 1 a2054480zex-1.txt EX-1 5460
3 EXHIBIT 2 a2054480zex-2.txt EX-2 1251
4 EXHIBIT 3 a2054480zex-3.txt EX-3 6388
5 EXHIBIT 4 a2054480zex-4.txt EX-4 2108
6 EXHIBIT 5 a2054480zex-5.txt EX-5 1940
7 EXHIBIT 6 a2054480zex-6.txt EX-6 3400
  Complete submission text file 0000912057-01-524320.txt   60632
Mailing Address ONE RAM RIDGE RD SPRING VALLEY NY 10977
Business Address ONE RAM RIDGE RD SPRING VALLEY NY 10977 9144257100
PHARMACEUTICAL RESOURCES INC (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: NJ | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-46121 | Film No.: 1684003
SIC: 2834 Pharmaceutical Preparations

Mailing Address 511 FIFTH AVENUE NEW YORK NY 10017
Business Address 3 DANIEL FRISCH STREET THE TOWER TEL AVIV ISRAEL 2125518881
IDB HOLDING CORP LTD (Filed by) CIK: 0000919593 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000